The global telmisartan market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 3.5% during 2021-2026.
Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a pres…